TWD
ANRO icon

True Wealth Design’s Alto Neuroscience ANRO Stock Holding History

True Wealth Design’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-126
Closed -$507 – 2860
2025
Q3 		$507 Sell
126
-81
-39% -$269 ﹤0.01% 2004
2025
Q2 		$456 Buy
+207
New +$493 ﹤0.01% 1784

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

True Wealth Design's ANRO Position: Q4 2025 in Review

True Wealth Design sold out of Alto Neuroscience (ANRO) in Q4 2025, closing a stake of 126 shares — an estimated $507 sold.

True Wealth Design first reported a position in ANRO in Q2 2025 and held it in 2 quarters. The position peaked at $507 in Q3 2025. 97 funds tracked by Wall St. Rank hold ANRO as of Q4 2025.

  • True Wealth Design reported no remaining Alto Neuroscience position as of Q4 2025 after selling out during the quarter.
  • True Wealth Design sold 126 Alto Neuroscience shares in Q4 2025, an estimated $507.
  • True Wealth Design first reported a position in Alto Neuroscience in Q2 2025 and held it in 2 quarters.
  • True Wealth Design's Alto Neuroscience position peaked at $507 in Q3 2025.
  • 97 funds tracked by Wall St. Rank held Alto Neuroscience as of Q4 2025.

Based on True Wealth Design's 13F filing for Q4 2025, filed 8 Jan 2026.